BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Ultragenyx Pharmaceutical
RARE
$2.6B
| $1.33M | ﹤0.01% |
17,008
-22,824
| -57% | -$1.51M |
|
|
SWAV
1552
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.32M | ﹤0.01% |
27,847
+19,464
| +232% | +$802K |
|
1553
Charles River Laboratories
CRL
$13.3B
| $1.31M | ﹤0.01% |
7,542
-19,091
| -72% | -$3.05M |
|
|
AYX
1554
PUT
DELISTED
Alteryx Inc
AYX
| $1.31M | ﹤0.01% |
80
| – | – |
|
1555
Cabot Corp
CBT
$4.52B
| $1.31M | ﹤0.01% |
35,399
+32,512
| +1,126% | +$1.09M |
|
1556
Sturm, Ruger & Co
RGR
$599M
| $1.31M | ﹤0.01% |
17,246
-3,456
| -17% | -$210K |
|
1557
AeroVironment
AVAV
$9.69B
| $1.31M | ﹤0.01% |
16,450
+5,823
| +55% | +$375K |
|
1558
PUT
First Solar
FSLR
$24.2B
| $1.31M | ﹤0.01% |
264
| – | – |
|
|
MZTI
1559
The Marzetti Company
MZTI
$3.17B
| $1.31M | ﹤0.01% |
8,428
-8,871
| -51% | -$1.29M |
|
1560
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.54B
| $1.3M | ﹤0.01% |
615
-166
| -21% | -$3.28K |
|
|
GNMK
1561
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.3M | ﹤0.01% |
88,550
+71,495
| +419% | +$726K |
|
1562
Addus HomeCare
ADUS
$2.16B
| $1.3M | ﹤0.01% |
14,047
+384
| +3% | +$33.2K |
|
1563
Chegg
CHGG
$88.8M
| $1.3M | ﹤0.01% |
19,257
-93,923
| -83% | -$5.02M |
|
1564
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $1.29M | ﹤0.01% |
32,494
-233,161
| -88% | -$8.63M |
|
1565
AGCO
AGCO
$7.05B
| $1.28M | ﹤0.01% |
23,087
-68,919
| -75% | -$3.59M |
|
|
SRDX
1566
DELISTED
Surmodics
SRDX
| $1.28M | ﹤0.01% |
29,589
+10,334
| +54% | +$391K |
|
1567
WEX
WEX
$6.58B
| $1.28M | ﹤0.01% |
7,751
-2,528
| -25% | -$347K |
|
1568
Affiliated Managers Group
AMG
$9.83B
| $1.27M | ﹤0.01% |
16,991
-3,140
| -16% | -$212K |
|
|
NUAN
1569
PUT
DELISTED
Nuance Communications, Inc.
NUAN
| $1.27M | ﹤0.01% |
500
+200
| +67% | +$4.18K |
|
|
RAVN
1570
DELISTED
Raven Industries Inc
RAVN
| $1.26M | ﹤0.01% |
58,714
-11,978
| -17% | -$253K |
|
1571
NCR Voyix
VYX
$1.13B
| $1.26M | ﹤0.01% |
118,666
+43,269
| +57% | +$496K |
|
1572
Macy's
M
$6.17B
| $1.26M | ﹤0.01% |
183,150
-131
| -0.1% | -$806 |
|
1573
Barclays
BCS
$94.7B
| $1.26M | ﹤0.01% |
222,245
+35,252
| +19% | +$184K |
|
|
BBBY
1574
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.26M | ﹤0.01% |
118,437
-190,374
| -62% | -$1.31M |
|
1575
CALL
Conagra Brands
CAG
$7.51B
| $1.25M | ﹤0.01% |
356
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.